86|0|Public
25|$|Arsenic {{is used as}} a feed {{additive}} in poultry and swine production, in particular in the U.S. to increase weight gain, improve feed efficiency, and to prevent disease. An example is <b>roxarsone,</b> which had been used as a broiler starter by about 70% of U.S. broiler growers. The Poison-Free Poultry Act of 2009 proposed to ban the use of <b>roxarsone</b> in industrial swine and poultry production. Alpharma, a subsidiary of Pfizer Inc., which produces <b>roxarsone,</b> voluntarily suspended sales of the drug in response to studies showing elevated levels of inorganic arsenic, a carcinogen, in treated chickens. A successor to Alpharma, Zoetis, continues to sell nitarsone, primarily for use in turkeys.|$|E
25|$|Large scale {{applications}} include its use as {{a precursor}} to forestry products, in colorless glass production, and in electronics. Being the main compound of arsenic, the trioxide is the precursor to elemental arsenic, arsenic alloys, and arsenide semiconductors. Organoarsenic compounds, e.g. feed additives (<b>Roxarsone)</b> and pharmaceuticals (Neosalvarsan), are derived from arsenic trioxide. Bulk arsenic-based compounds sodium arsenite and sodium cacodylate are derived from the trioxide.|$|E
2500|$|The monomethylated acid, methanearsonic acid (CH3AsO(OH)2), is a {{precursor}} to fungicides (tradename Neoasozin) in the cultivation of rice and cotton. [...] Derivatives of phenylarsonic acid (C6H5AsO(OH)2) are used as feed additives for livestock, including 4-hydroxy-3-nitrobenzenearsonic acid (3-NHPAA or <b>Roxarsone),</b> ureidophenylarsonic acid, and [...] p-arsanilic acid. [...] These applications are controversial as they introduce soluble forms of arsenic into the environment.|$|E
2500|$|Poultry feed {{can also}} include <b>roxarsone</b> or nitarsone, arsenical {{antimicrobial}} drugs that also promote growth. <b>Roxarsone</b> {{was used as}} a broiler starter by about 70% of the broiler growers between 1995 and 2000. The drugs have generated controversy because it contains arsenic, which is highly toxic to humans. [...] This arsenic could be transmitted through run-off from the poultry yards. [...] A 2004 study by the U.S. magazine Consumer Reports reported [...] "no detectable arsenic in our samples of muscle" [...] but found [...] "A few of our chicken-liver samples has an amount that according to EPA standards could cause neurological problems in a child who ate 2 ounces of cooked liver per week or in an adult who ate 5.5 ounces per week." [...] The U.S. Food and Drug Administration (FDA), however, is the organization responsible for the regulation of foods in America, and all samples tested were [...] "far less than the... amount allowed in a food product." ...|$|E
2500|$|Anthropogenic (man-made) {{sources of}} arsenic, like the natural sources, are mainly arsenic oxides and the {{associated}} anions. Man-made sources of arsenic, include wastes from mineral processing, swine and poultry farms. For example, many ores, especially sulfide minerals, are contaminated with arsenic, which is released in roasting (burning in air). In such processing, arsenide is converted to arsenic trioxide, which is volatile at high temperatures and is released into the atmosphere. Poultry and swine farms make heavy use of the organoarsenic compound <b>roxarsone</b> as an antibiotic in feed. Some wood is treated with copper arsenates as a preservative. The mechanisms by which these sources affect [...] "downstream" [...] living organisms remains uncertain but are probably diverse. One commonly cited pathway involves methylation.|$|E
5000|$|<b>Roxarsone</b> has {{attracted}} attention {{as a source}} of arsenic contamination of poultry and other foods. In July 2011, Pfizer suspended sale of <b>roxarsone</b> in the U.S. in response {{to a study by the}} Food and Drug Administration (FDA); the FDA found that <b>roxarsone</b> use was associated with elevated levels of inorganic arsenic in chicken livers. An FDA press release stated that the findings raised [...] "concerns of a very low but completely avoidable exposure to a carcinogen." [...] The voluntary suspension does not preempt Pfizer from selling <b>roxarsone</b> in the future, as FDA has not withdrawn its approval to market the drug in the U.S. As of 2011, <b>roxarsone</b> was approved for use in 14 other countries as well.|$|E
50|$|<b>Roxarsone</b> is an organoarsenic {{compound}} that {{is widely used}} in poultry production as a feed additive to increase weight gain and improve feed efficiency, and as a coccidiostat. The drug is also approved in the United States for use in pigs. <b>Roxarsone</b> is marketed as 3-Nitro by Zoetis, a former subsidiary of Pfizer now a publicly traded company. In 2006, approximately one million kilograms of <b>roxarsone</b> were produced in the U.S.|$|E
50|$|<b>Roxarsone</b> {{is one of}} four arsenical animal drugs {{approved}} by the U.S. Food and Drug Administration (FDA) for use in poultry and/or swine, along with nitarsone, arsanilic acid, and carbarsone. In September 2013, the FDA announced that Zoetis and Fleming Laboratories would voluntarily withdraw current <b>roxarsone,</b> arsanilic acid, and carbarsone approvals, leaving only nitarsone approvals in place. In 2015 FDA withdraw the approval of using nitarsone in animal feeds. The ban came into effect at the end of 2015. <b>Roxarsone</b> is banned in the European Union.|$|E
50|$|A 2013 market basket study {{linked the}} use of <b>roxarsone</b> and other arsenical feed {{additives}} to increased levels of inorganic arsenic in chicken breast meat. Breast meat from conventionally produced chickens (in which arsenical use is permitted under U.S. law) had three times more inorganic arsenic than did breast meat from chickens produced according to USDA Organic standards. The USDA Organic program prohibits arsenical use in organic chicken production. The researchers also found that inorganic arsenic concentrations were almost three times higher in samples with detectable levels of <b>roxarsone</b> than in samples without detectable <b>roxarsone.</b>|$|E
5000|$|... #Caption: <b>Roxarsone</b> is an organoarsenic {{compound}} used as {{an animal}} feed.|$|E
5000|$|... #Caption: <b>Roxarsone,</b> a {{controversial}} arsenic compound {{used as a}} nutritional supplement for chickens.|$|E
50|$|Arsenic {{is used as}} a feed {{additive}} in poultry and swine production, in particular in the U.S. to increase weight gain, improve feed efficiency, and to prevent disease. An example is <b>roxarsone,</b> which had been used as a broiler starter by about 70% of U.S. broiler growers. The Poison-Free Poultry Act of 2009 proposed to ban the use of <b>roxarsone</b> in industrial swine and poultry production. Alpharma, a subsidiary of Pfizer Inc., which produces <b>roxarsone,</b> voluntarily suspended sales of the drug in response to studies showing elevated levels of inorganic arsenic, a carcinogen, in treated chickens. A successor to Alpharma, Zoetis, continues to sell nitarsone, primarily for use in turkeys.|$|E
5000|$|... #Caption: <b>Roxarsone</b> is a {{controversial}} arsenic compound {{used as a}} feed ingredient for chickens.|$|E
50|$|Nitarsone {{is one of}} four arsenical animal drugs {{approved}} by the U.S. Food and Drug Administration for use in poultry, along with <b>roxarsone,</b> arsanilic acid, and carbarsone. Following the 2011 suspension of <b>roxarsone</b> sales in the United States, however, it {{is believed to be the}} only arsenical animal drug currently marketed in the U.S. In September 2013, the FDA announced that Zoetis and Fleming Laboratories would voluntarily withdraw current <b>roxarsone,</b> arsanilic acid, and carbarsone approvals, leaving only nitarsone approvals in place. When the withdrawals occurred, nitarsone was only arsenical approved for use in food animals in the U.S. In 2015 FDA withdrew the approval of using nitarsone in animal feeds. The ban came into effect at the end of 2015.|$|E
50|$|Carbarsone {{is one of}} four arsenical animal drugs {{approved}} by the U.S. Food and Drug Administration for use in poultry and/or swine, along with nitarsone, arsanilic acid, and <b>roxarsone.</b> In September 2013, the FDA announced that Zoetis and Fleming Laboratories would voluntarily withdraw current <b>roxarsone,</b> arsanilic acid, and carbarsone approvals, leaving only nitarsone approvals in place. In 2015 FDA withdrew the approval of using nitarsone in animal feeds. The ban came into effect at the end of 2015.|$|E
50|$|Several {{derivatives}} of {{phenylarsonic acid}} {{have been used}} as additives for animal feeds. These include 4-hydroxy-3-nitrobenzenearsonic acid (3-NHPAA, or <b>Roxarsone),</b> p-arsanilic acid (p-ASA), 4-nitrophenylarsonic acid (4-NPAA), and p-ureidophenylarsonic acid (p-UPAA).|$|E
50|$|<b>Roxarsone</b> is a {{derivative}} of phenylarsonic acid (C6H5As(O)(OH)2). It was first {{reported in a}} 1923 British patent that described the nitration and diazotization of arsanilic acid. When blended with calcite powder, it is used in poultry feed premixes and is usually available in 5%, 20% and 50% concentrations.|$|E
5000|$|In factory farming, {{chickens}} {{are routinely}} administered with the feed additive <b>Roxarsone,</b> an organoarsenic compound which partially decomposes into inorganic arsenic compounded {{in the flesh}} of chickens, and in their feces, which are often used as a fertilizer. The compound is used to control stomach pathogens and promote growth. In a 2013 sample conducted by the Johns Hopkins School of Public Health of chicken meat from poultry producers that did not prohibit <b>roxarsone,</b> 70% of the samples in the US had levels which exceeded the safety limits as set by the FDA. The FDA has since revised its stance on safe limits to inorganic arsenic in animal feed by stating that [...] "any new animal drug {{that contributes to the}} overall inorganic arsenic burden is of potential concern".|$|E
50|$|The monomethylated acid, methanearsonic acid (CH3AsO(OH)2), is a {{precursor}} to fungicides (tradename Neoasozin) in the cultivation of rice and cotton. Derivatives of phenylarsonic acid (C6H5AsO(OH)2) are used as feed additives for livestock, including 4-hydroxy-3-nitrobenzenearsonic acid (3-NHPAA or <b>Roxarsone),</b> ureidophenylarsonic acid, and p-arsanilic acid. These applications are controversial as they introduce soluble forms of arsenic into the environment.|$|E
5000|$|Poultry feed {{can also}} include <b>roxarsone</b> or nitarsone, arsenical {{antimicrobial}} drugs that also promote growth. <b>Roxarsone</b> {{was used as}} a broiler starter by about 70% of the broiler growers between 1995 and 2000. The drugs have generated controversy because it contains arsenic, which is highly toxic to humans. This arsenic could be transmitted through run-off from the poultry yards. A 2004 study by the U.S. magazine Consumer Reports reported [...] "no detectable arsenic in our samples of muscle" [...] but found [...] "A few of our chicken-liver samples has an amount that according to EPA standards could cause neurological problems in a child who ate 2 ounces of cooked liver per week or in an adult who ate 5.5 ounces per week." [...] The U.S. Food and Drug Administration (FDA), however, is the organization responsible for the regulation of foods in America, and all samples tested were [...] "far less than the... amount allowed in a food product." ...|$|E
50|$|Large scale {{applications}} include its use as {{a precursor}} to forestry products, in colorless glass production, and in electronics. Being the main compound of arsenic, the trioxide is the precursor to elemental arsenic, arsenic alloys, and arsenide semiconductors. Organoarsenic compounds, e.g. feed additives (<b>Roxarsone)</b> and pharmaceuticals (Neosalvarsan), are derived from arsenic trioxide. Bulk arsenic-based compounds sodium arsenite and sodium cacodylate are derived from the trioxide.|$|E
50|$|Arsenic is a {{ubiquitous}} element {{present in}} American drinking water. In the United States, levels of arsenic that are above natural levels, but still well below danger levels set in federal safety standards, {{have been detected}} in commercially raised chickens. The source of the arsenic {{appears to be the}} feed additives <b>roxarsone</b> and nitarsone, which are used to control the parasitic infection coccidiosis as well as to increase weight and skin coloring of the poultry.|$|E
5000|$|Natural and {{contaminant}} {{organometallic compounds}} {{are found in}} the environment. Some that are remnants of human use, such as organolead and organomercury compounds, are toxicity hazards. Tetraethyllead was prepared for use as a gasoline additive but has fallen into disuse because of lead's toxicity. Its replacements are other organometallic compounds, such as ferrocene and methylcyclopentadienyl manganese tricarbonyl (MMT). The organoarsenic compound <b>roxarsone</b> is a controversial animal feed additive. In 2006, approximately one million kilograms of it were produced in the U.S alone.|$|E
5000|$|Arsanilic acid gained {{use as a}} feed {{additive}} for poultry and swine to promote growth and prevent or treat dysentery. [...] For poultry and swine, arsanilic acid was among four arsenical veterinary drugs, along with carbarsone, nitarsone, <b>roxarsone,</b> approved by the U.S. Food and Drug Administration (FDA). [...] In 2013, the FDA denied petitions by the Center for Food Safety and by the Institute for Agriculture and Trade Policy seeking revocation of approvals of the arsenical animal drugs, but the drugs' sponsors voluntarily requested the FDA to withdraw approvals of three, including arsanilic acid, leaving only nitarsone approved. [...] In 2015, the FDA withdrew nitarsone's approval. Arsanilic acid is still used in the laboratory, for instance in recent modification of nanoparticles.|$|E
5000|$|Anthropogenic (man-made) {{sources of}} arsenic, like the natural sources, are mainly arsenic oxides and the {{associated}} anions. Man-made sources of arsenic, include wastes from mineral processing, swine and poultry farms. For example, many ores, especially sulfide minerals, are contaminated with arsenic, which is released in roasting (burning in air). In such processing, arsenide is converted to arsenic trioxide, which is volatile at high temperatures and is released into the atmosphere. Poultry and swine farms make heavy use of the organoarsenic compound <b>roxarsone</b> as an antibiotic in feed. Some wood is treated with copper arsenates as a preservative. The mechanisms by which these sources affect [...] "downstream" [...] living organisms remains uncertain but are probably diverse. One commonly cited pathway involves methylation.|$|E
40|$|ABSTRACT Six {{trials were}} {{conducted}} at various locations {{to determine the}} response of broiler chickens to combinations of zinc bacitracin and <b>roxarsone</b> when fed {{in the presence of}} narasin. The addition of zinc bacitracin at 55 mg per kg significantly improved growth rate and feed utilization when data from all locations were combined. There was no effect of <b>roxarsone</b> fed at 50 mg per kg on BW or feed utilization, nor was there an interaction of <b>roxarsone</b> and zinc bacitracin on BW. There was a significant interaction of <b>roxarsone</b> and zinc bacitracin for feed utilization; addition of zinc bacitracin significantly improved feed utilization both in the presence and absence of <b>roxarsone,</b> but the improvement was greater in the absence of <b>roxarsone.</b> {Key words: zinc bacitracin, <b>roxarsone,</b> feed additives, body weight, narasin) 1990 Poultry Science 69 : 898 - 901 INTRODUCTION and <b>roxarsone</b> significantly increased BW _,,., gains and improved feed utilization (Waldroup <b>Roxarsone</b> and other organic arsenical com-et fl / 1 9 8 6 a) Z i n c b a c i t r a c i n significantly pounds have long been reported to enhance improve...|$|E
40|$|Experiment was {{conducted}} to {{examine the effect of}} dietary <b>roxarsone</b> (3 -nitro- 4 hydroxyphemylarsonic acid) on Cu utilization by chick. A fortified corn-soybean meal diet was fed to the chick. <b>Roxarsone</b> dramatically reduced liver cu concentration at all levels of supplemental Cu fed. The level of <b>roxarsone</b> commonly fed, 50 mg/kg diet, resulted in a twoto-four fold depression in liver Cu concentration in chick. The effects of <b>roxarsone</b> on weight gain were more perplexity. In the chick, the diets containing 100 and 250 mg Cu/kg depressed growth in the presence, but not in the absence, of 50 mg/kg dietary <b>roxarsone.</b> In contrast, at toxic levels of Cu, <b>roxarsone</b> had no effect on (500 or 750 mg Cu/kg diet) the growthdepressing effects of Cu/kg diet) the growth-depressing effects of Cu...|$|E
40|$|Although {{microbial}} {{activity and}} associated iron (oxy) hydroxides are known in general {{to affect the}} environmental dynamics of 4 -hydroxy- 3 -nitrobenzenearsonic acid (<b>roxarsone),</b> the mechanistic understanding of the underlying biophysico-chemical processes remains unclear due to limited experimental information. We studied how Shewanella oneidensis MR- 1 -a widely distributed metal-reducing bacterium, {{in the presence of}} dissolved Fe(III), affects <b>roxarsone</b> transformations and biogeochemical cycling in a model aqueous system. The results showed that the MR- 1 strain was able to anaerobically use <b>roxarsone</b> as a terminal electron acceptor and to convert it to a single product, 3 -amino- 4 -hydroxybenzene arsonic acid (AHBAA). The presence of Fe(III) stimulated <b>roxarsone</b> transformation via MR- 1 -induced Fe(III) reduction, whereby the resulting Fe(II) acted as an efficient reductant for <b>roxarsone</b> transformation. In addition, the subsequent secondary Fe(III) /Fe(II) mineralization created conditions for adsorption of organoarsenic compounds to the yielded precipitates and thereby led to arsenic immobilization. The study provided direct evidence of Shewanella oneidensis MR- 1 -induced direct and Fe(II) -associated <b>roxarsone</b> transformation. Quantitative estimations revealed a candidate mechanism for the early-stage environmental dynamics of <b>roxarsone</b> in nature, which is essential for understanding the environmental dynamics of <b>roxarsone</b> and successful risk assessment...|$|E
40|$|<b>Roxarsone</b> (3 -nitro- 4 -hydroxyphenylarsonic acid) {{has been}} widely used as a feed {{additive}} to control coccidial intestinal parasites and to enhance feed efficiency in poultry industry. Nearly all the <b>roxarsone</b> is excreted unchanged {{and part of that}} enters animal wastewater and surface water through washing and runoff, posing potential risk to aquatic environment. Suspended particulate matter with a huge specific surface area and a large number of active groups may combine <b>roxarsone</b> onto its surface and determine the fate of <b>roxarsone</b> in aquatic environment. Clays are important components of suspended particulate matter and exhibit good sorption properties for various kinds of pollutants in aquatic environment. In this work, the sorption of <b>roxarsone</b> to three typical natural clay minerals, i. e., kaolinite, illite and montmorillonite, was investigated. The results indicated that 1) <b>Roxarsone</b> can be spontaneously sorbed on natural clay minerals and more easily sorbed at higher temperatures. 2) Ferric ion with a concentration of 0 - 5 mM significantly promoted <b>roxarsone</b> sorption by forming bridging complexation, while divalent calcium ion and divalent magnesium ions exhibit an inhibitory effect on <b>roxarsone</b> sorption. 3) pH has obvious effect on the sorption and the maximum sorption occurs at pH about 9. 0, 5. 0 and 5. 0 for kaolinite, illite and montmorillonite, respectively...|$|E
40|$|ABSTRACT The {{anticoccidial}} {{activity of}} lasalocid, monensin, and <b>roxarsone,</b> alone and in combination, was evaluated against eleven Eimeria tenella recent field isolates. Lasalocid was used at 0. 0075, 0. 01, and 0. 0125 % active drug in feed; monensin at 0. 0099 and 0. 0121 %; and <b>roxarsone</b> at 0. 005 %. Further studies with lasalocid 0. 0075 %, monensin 0. 0099 % and <b>roxarsone</b> 0. 005 and 0. 0025 % combinations {{were carried out}} against three E. tenella field isolates selected from the aforementioned strains. Lasalocid and monensin each exhibited {{a high degree of}} anticoccidial activity at all concentrations tested. Lasalocid and monensin fed in combination with <b>roxarsone</b> showed, in addition to high anticoccidial activity a further reduction in gross lesions and oocysts production, more pronounced at 0. 005 % level of <b>roxarsone</b> than at 0. 0025 %, compared to either medication alone or the <b>roxarsone</b> combinations. These positive effects were noted with all strains tested. The practical aspects of these findings are discussed...|$|E
40|$|The organoarsenical <b>roxarsone</b> {{is added}} to poultry feed to {{increase}} weight gain. Studies have shown that <b>roxarsone</b> does not accumulate in poultry tissue but is excreted, resulting in elevated arsenic concentrations (~ 40 mg/kg) in poultry litter. However, there is little understanding of the fate of <b>roxarsone</b> once it is introduced into agricultural watersheds. Using batch experiments, I investigated the sorption characteristics of <b>roxarsone</b> to Ap and Bt soils of the Frederick series, common in the Shenandoah Valley of Virginia, an area of intense poultry production. Results demonstrate that <b>roxarsone</b> sorbs strongly to Bt soils, but only showed moderate to low sorption onto Ap soils. Sorption to the Ap soils demonstrated stronger pH dependence than did sorption to the Bt soils. Removing organic matter (OM) from Ap soils significantly changed the sorption characteristics, suggesting that OM may be coating mineral surfaces in these soils. Results of this study have implications for <b>roxarsone</b> transport i...|$|E
40|$|Sorption uptake {{kinetics}} and equilibrium {{studies for}} 4 -hydroxy- 3 -nitrobenzene arsonic acid (<b>roxarsone)</b> was evaluated with synthetic magnetite (Mag-P), commercial magnetite (Mag-C), magnetite 10 %, 19 %, and 32 % composite material (CM- 10, - 19, - 32) that contains {{granular activated carbon}} (GAC), and synthetic goethite at pH 7. 00 in water at 21 Â°C for 24 h. GAC showed the highest sorptive removal of <b>roxarsone</b> and the relative uptake for each sorbent material with <b>roxarsone</b> are listed in descending order as follows: GAC (471 mg/g) > goethite (418 mg/g) > CM- 10 (377 mg/g) CM- 19 (254 mg/g) > CM- 32 (227 mg/g) > Mag-P (132 mg/g) > Mag-C (29. 5 mg/g). The As (V) moiety of <b>roxarsone</b> is adsorbed {{onto the surface of}} the iron oxide/oxyhydrate and is inferred as inner-sphere surface complexes; monodentate-mononuclear, bidentate-mononuclear, and bidentate-binuclear depending on the protolytic speciation of <b>roxarsone.</b> The phenyl ring of <b>roxarsone</b> provides the primary driving force for the sorptive interaction with the graphene surface of GAC and its composites. Thus, magnetite composites are proposed as multi-purpose adsorbents for the co-removal of inorganic and organic arsenicals due to the presence of graphenic and iron oxide active adsorption sites...|$|E
40|$|A {{trial was}} {{conducted}} {{to examine the effects}} of the interaction of an organic arsenical compound (<b>roxarsone)</b> : 3 -nitro- 4 -hydroxy-phenylarsonic acid and copper sulfate on the egg production, liver function, and the copper content of the liver, eggs and excreta of laying hens. The experiment was a 2 x 3 factorial design with three replications. Ninety 38 -weeks-old layer hens were selected from a commercial flock, and placed into six dietary treatments, i. e. two levels of <b>roxarsone</b> (0, 50 mg kg(- 1)) and three levels of supplementary copper (400, 500, 600 mg kg(- 1)), with five layer hens in each cage. Feeding was undertaken for four weeks. The interaction between copper and <b>roxarsone</b> in the diet significantly influenced the feed intake, egg production, and copper content in the liver and excreta (P 0. 05). With all supplement levels of copper, the copper concentration in both the liver and egg were significantly depressed by adding <b>roxarsone</b> to the diet. Without the <b>roxarsone</b> supplement, increased levels of copper supplements also significantly depressed the copper content in the eggs (P< 0. 05). In all diets, both with and without <b>roxarsone,</b> the copper content in excreta of layers significantly increased as the level of supplemental copper increased (P< 0. 05). The rate of copper excretion increased significantly more with the diet containing added <b>roxarsone</b> as supplemental copper increased from 400 to 500 mg kg(- 1). The response of serum aspartate aminotransferase (AST) and creatine kinase (CK) to the dietary supplement of copper and <b>roxarsone</b> was inconsistent. However. lactate dehydrogenase (LDH) activity increased significantly (P< 0. 05). High dietary copper (500 or 600 mg kg(- 1)) diets increased the serum LDH activity significantly (P< 0. 05) with the <b>roxarsone</b> inclusion in the diet at the end of the first weel; of feeding. With the dietary inclusion of <b>roxarsone,</b> the LDH enzyme activity also significantly (P< 0. 05) raised in the high copper diet of 500 mg kg(- 1) on the third week. and in all levels of copper on the forth week. Liver damage was also observed with the bile duct proliferation and hepatocyte degeneration. (C) 1998 Elsevier Science B. V...|$|E
40|$|BACKGROUND: <b>Roxarsone</b> (3 -nitro- 4 -hydroxy benzene arsonic acid) is an arsenic {{compound}} {{widely used}} in the poultry industry as a feed additive to prevent coccidiosis, stimulate growth, and to improve tissue pigmentation. Little {{is known about the}} potential human health effects from <b>roxarsone</b> released into the environment from chicken waste or from residual compound in chicken products. OBJECTIVE: The growth potentiation and enhanced tissue pigmentation suggest that low levels of <b>roxarsone</b> exposure may have an angiogenic potential similar to that of inorganic arsenite (AsIII). The goal of this investigation was to test the hypothesis described above using cultured human aortic and lung microvascular endothelial cells in high-content imaging tube-forming assays and begin developing a molecular level understanding of the process. METHODS: We used a three-dimensional Matrigel assay for probing angiogenesis in cultured human endothelial cells, and a polymerase chain reaction (PCR) array to probe the gene changes as a function of <b>roxarsone</b> or AsIII treatment. In addition, we used Western blot analysis for changes in protein concentration and activation. RESULTS: <b>Roxarsone</b> was found to exhibit a higher angiogenic index than AsIII at lower concentrations. Increased endothelial nitric oxide synthase (eNOS) activity was observed for <b>roxarsone</b> but not for AsIII-induced angiogenesis. However, AsIII caused more rapid and pronounced phosphorylation of eNOS. Quantitative PCR array on select genes revealed that the two compounds have different and often opposite effects on angiogenic gene expression. CONCLUSIONS: The results demonstrate that <b>roxarsone</b> and AsIII promote angiogenic phenotype in human endothelial cells through distinctly different signaling mechanisms...|$|E
40|$|Organoarsenicals are {{commonly}} used for growth promotion in U. S. poultry production. Susceptibilities to arsenite, arsenate, and the organoarsenical <b>roxarsone</b> were measured in 251 Campylobacter isolates from conventional and antimicrobial-free retail poultry products. Isolates from conventional poultry products had significantly higher <b>roxarsone</b> MICs (z = 8. 22; P < 0. 0001) ...|$|E
40|$|A {{method has}} been {{developed}} to measure the levels of the growth promoter 4 -hydroxy- 3 -nitrophenylarsonic acid (<b>roxarsone)</b> in samples of tissue from chickens fed on a diet supplemented with this compound. Extracts of the tissue were prepared for analysis by a trypsin enzymolysis digestion technique and bulk matrix separation was performed by anion-exchange column chromatography. Further separation of the <b>roxarsone</b> from other species was achieved using reversed-phase high-performance liquid chromatography. Detection of the arsenical compound was by inductively coupled plasma mass spectrometry. No <b>roxarsone</b> was detected in chickens fed on the supplemented diet {{with or without a}} withdrawal period (7 d on base feed after the administration period) at a quantification limit of 25 ng g- 1. Recoveries for <b>roxarsone</b> from spiked (standard additions) samples of chicken tissue varied between 85 and 103 %...|$|E
